{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:40:26Z","timestamp":1792680026752,"version":"4.5.0"},"reference-count":186,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10815-026-03941-y","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:10:43Z","timestamp":1781939443000},"page":"1985-2001","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of anti-M\u00fcllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy"],"prefix":"10.1007","volume":"43","author":[{"given":"Irene","family":"Peregrin-Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Zemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri Lynn","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah Michelle","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie Jane","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaou-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momal","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Detti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"3941_CR1","unstructured":"Williams CJ, Erickson GF. Morphology and Physiology of the Ovary. 2012 Jan 30. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferr\u00e8re B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000\u2013. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278943\/"},{"key":"3941_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tem.2009.10.001","volume":"21","author":"P Reddy","year":"2010","unstructured":"Reddy P, Zheng W, Liu K. Mechanisms maintaining the dormancy and survival of mammalian primordial follicles. Trends Endocrinol Metab. 2010;21:96\u2013103. https:\/\/doi.org\/10.1016\/j.tem.2009.10.001.","journal-title":"Trends Endocrinol Metab"},{"key":"3941_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ydbio.2008.06.017","volume":"321","author":"GB John","year":"2008","unstructured":"John GB, Gallardo TD, Shirley LJ, Castrillon DH. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol. 2008;321:197\u2013204. https:\/\/doi.org\/10.1016\/j.ydbio.2008.06.017.","journal-title":"Dev Biol"},{"key":"3941_CR4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s10815-020-01790-x","volume":"37","author":"MI Albamonte","year":"2020","unstructured":"Albamonte MI, Calabr\u00f3 LY, Albamonte MS, Zuccardi L, Stella I, Halperin J, et al. PTEN and FOXO3 expression in the prenatal and postnatal human ovary. J Assist Reprod Genet. 2020;37:1613\u201322. https:\/\/doi.org\/10.1007\/s10815-020-01790-x.","journal-title":"J Assist Reprod Genet"},{"key":"3941_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/humupd\/dmi020","volume":"11","author":"MK Skinner","year":"2005","unstructured":"Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update. 2005;11:461\u201371. https:\/\/doi.org\/10.1093\/humupd\/dmi020.","journal-title":"Hum Reprod Update"},{"key":"3941_CR6","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.2741\/2339","volume":"12","author":"J Craig","year":"2007","unstructured":"Craig J, Orisaka M, Wang H, Orisaka S, Thompson W, Zhu C. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front Biosci. 2007;12:3628\u201339. https:\/\/doi.org\/10.2741\/2339.","journal-title":"Front Biosci"},{"key":"3941_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.33590\/emj\/10310672","volume":"3","author":"S-Y Kim","year":"2018","unstructured":"Kim S-Y, Kurita T. New insights into the role of phosphoinositide 3-kinase activity in the physiology of immature oocytes: lessons from recent mouse model studies. Eur J Med Res. 2018;3:119\u201325. https:\/\/doi.org\/10.33590\/emj\/10310672.","journal-title":"Eur J Med Res"},{"key":"3941_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/bs.vh.2018.01.015","volume":"107","author":"SLP Regan","year":"2018","unstructured":"Regan SLP, Knight PG, Yovich JL, Leung Y, Arfuso F, Dharmarajan A. Involvement of bone morphogenetic proteins (BMP) in the regulation of ovarian function. Vitam Horm. 2018;107:227\u201361. https:\/\/doi.org\/10.1016\/bs.vh.2018.01.015.","journal-title":"Vitam Horm"},{"key":"3941_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2014-1020","volume":"36","author":"AJW Hsueh","year":"2015","unstructured":"Hsueh AJW, Kawamura K, Cheng Y, Fauser BCJM. Intraovarian control of early folliculogenesis. Endocr Rev. 2015;36:1\u201324. https:\/\/doi.org\/10.1210\/er.2014-1020.","journal-title":"Endocr Rev"},{"key":"3941_CR10","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1093\/humrep\/deq275","volume":"25","author":"O Oktem","year":"2010","unstructured":"Oktem O, Urman B. Understanding follicle growth in vivo. Hum Reprod. 2010;25:2944\u201354. https:\/\/doi.org\/10.1093\/humrep\/deq275.","journal-title":"Hum Reprod"},{"key":"3941_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1071\/RD09218","volume":"22","author":"M Binelli","year":"2010","unstructured":"Binelli M, Murphy BD. Coordinated regulation of follicle development by germ and somatic cells. Reprod Fertil Dev. 2010;22:1\u201312. https:\/\/doi.org\/10.1071\/RD09218.","journal-title":"Reprod Fertil Dev"},{"key":"3941_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061491","volume":"10","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Feng H, Zhang Y, Zhang JV, Wang X, Liu D, et al. Current understandings of core pathways for the activation of mammalian primordial follicles. Cells. 2021;10:1491. https:\/\/doi.org\/10.3390\/cells10061491.","journal-title":"Cells"},{"key":"3941_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/oxfordjournals.humrep.a136365","volume":"1","author":"A Gougeon","year":"1986","unstructured":"Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod. 1986;1:81\u20137. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a136365.","journal-title":"Hum Reprod"},{"key":"3941_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ando.2010.02.021","volume":"71","author":"A Gougeon","year":"2010","unstructured":"Gougeon A. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. Ann Endocrinol (Paris). 2010;71:132\u201343. https:\/\/doi.org\/10.1016\/j.ando.2010.02.021.","journal-title":"Ann Endocrinol (Paris)"},{"key":"3941_CR15","doi-asserted-by":"publisher","DOI":"10.3843\/glowm.10289","author":"GF Erickson","year":"2009","unstructured":"Erickson GF. Follicle growth and development. Glob Libr Women S Med. 2009. https:\/\/doi.org\/10.3843\/glowm.10289.","journal-title":"Glob Libr Women S Med"},{"key":"3941_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S. Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016;22:709\u201324. https:\/\/doi.org\/10.1093\/humupd\/dmw027.","journal-title":"Hum Reprod Update"},{"key":"3941_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.575706","volume":"8","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang W, Shi X, Zhang C, Song G, Huang D. The factors and pathways regulating the activation of mammalian primordial follicles in vivo. Front Cell Dev Biol. 2020;8:575706. https:\/\/doi.org\/10.3389\/fcell.2020.575706.","journal-title":"Front Cell Dev Biol"},{"key":"3941_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0303-7207(01)00467-1","volume":"179","author":"N Josso","year":"2001","unstructured":"Josso N, di Clemente N, Gou\u00e9dard L. Anti-M\u00fcllerian hormone and its receptors. Mol Cell Endocrinol. 2001;179:25\u201332. https:\/\/doi.org\/10.1016\/s0303-7207(01)00467-1.","journal-title":"Mol Cell Endocrinol"},{"key":"3941_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0044-1786732","volume":"42","author":"S Yildiz","year":"2024","unstructured":"Yildiz S, Moolhuijsen LME, Visser JA. The role of anti-M\u00fcllerian hormone in ovarian function. Semin Reprod Med. 2024;42:15\u201324. https:\/\/doi.org\/10.1055\/s-0044-1786732.","journal-title":"Semin Reprod Med"},{"key":"3941_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010200","volume":"9","author":"M Maidarti","year":"2020","unstructured":"Maidarti M, Anderson RA, Telfer EE. Crosstalk between PTEN\/PI3K\/Akt signalling and DNA damage in the oocyte: implications for primordial follicle activation, oocyte quality and ageing. Cells. 2020;9:200. https:\/\/doi.org\/10.3390\/cells9010200.","journal-title":"Cells"},{"key":"3941_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1210\/endrev\/bnac013","volume":"43","author":"KL Clark","year":"2022","unstructured":"Clark KL, George JW, Przygrodzka E, Plewes MR, Hua G, Wang C, et al. Hippo signaling in the ovary: emerging roles in development, fertility, and disease. Endocr Rev. 2022;43:1074\u201396. https:\/\/doi.org\/10.1210\/endrev\/bnac013.","journal-title":"Endocr Rev"},{"key":"3941_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133775","volume":"13","author":"S Fountas","year":"2024","unstructured":"Fountas S, Petinaki E, Bolaris S, Kargakou M, Dafopoulos S, Zikopoulos A, et al. The roles of GDF-9, BMP-15, BMP-4 and EMMPRIN in folliculogenesis and in vitro fertilization. J Clin Med. 2024;13:3775. https:\/\/doi.org\/10.3390\/jcm13133775.","journal-title":"J Clin Med"},{"key":"3941_CR23","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/humrep\/dey250","volume":"33","author":"J Grosbois","year":"2018","unstructured":"Grosbois J, Demeestere I. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod. 2018;33:1705\u201314. https:\/\/doi.org\/10.1093\/humrep\/dey250.","journal-title":"Hum Reprod"},{"key":"3941_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s1472-6483(10)60347-1","volume":"15","author":"R Palermo","year":"2007","unstructured":"Palermo R. Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online. 2007;15:326\u201337. https:\/\/doi.org\/10.1016\/s1472-6483(10)60347-1.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1749-6632.2010.05660.x","volume":"1205","author":"IE Messinis","year":"2010","unstructured":"Messinis IE, Messini CI, Dafopoulos K. The role of gonadotropins in the follicular phase. Ann N Y Acad Sci. 2010;1205:5\u201311. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05660.x.","journal-title":"Ann N Y Acad Sci"},{"key":"3941_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bpobgyn.2018.05.005","volume":"55","author":"R Lew","year":"2019","unstructured":"Lew R. Natural history of ovarian function including assessment of ovarian reserve and premature ovarian failure. Best Pract Res Clin Obstet Gynaecol. 2019;55:2\u201313. https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.05.005.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3941_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s10815-022-02456-6","volume":"39","author":"L Casarini","year":"2022","unstructured":"Casarini L, Paradiso E, Lazzaretti C, D\u2019Alessandro S, Roy N, Mascolo E, et al. Regulation of antral follicular growth by an interplay between gonadotropins and their receptors. J Assist Reprod Genet. 2022;39:893\u2013904. https:\/\/doi.org\/10.1007\/s10815-022-02456-6.","journal-title":"J Assist Reprod Genet"},{"key":"3941_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/rmb2.12371","volume":"20","author":"M Orisaka","year":"2021","unstructured":"Orisaka M, Miyazaki Y, Shirafuji A, Tamamura C, Tsuyoshi H, Tsang BK, et al. The role of pituitary gonadotropins and intraovarian regulators in follicle development: a mini-review. Reprod Med Biol. 2021;20:169\u201375. https:\/\/doi.org\/10.1002\/rmb2.12371.","journal-title":"Reprod Med Biol"},{"key":"3941_CR29","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/REP-19-0201","volume":"159","author":"EA Ford","year":"2020","unstructured":"Ford EA, Beckett EL, Roman SD, McLaughlin EA, Sutherland JM. Advances in human primordial follicle activation and premature ovarian insufficiency. J Reprod Fertil. 2020;159:R15-29. https:\/\/doi.org\/10.1530\/REP-19-0201.","journal-title":"J Reprod Fertil"},{"key":"3941_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12921","author":"X Meng","year":"2023","unstructured":"Meng X, Peng L, Wei X, Li S. FOXO3 is a potential biomarker and therapeutic target for premature ovarian insufficiency (review). Mol Med Rep. 2023. https:\/\/doi.org\/10.3892\/mmr.2022.12921.","journal-title":"Mol Med Rep"},{"key":"3941_CR31","doi-asserted-by":"publisher","unstructured":"Adhikari D, Zheng W, Shen Y, Gorre N, H\u00e4m\u00e4l\u00e4inen T, Cooney AJ, et al. Tsc\/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles. Hum Mol Genet [Internet]. 2010;19:397\u2013410. Available from: https:\/\/doi.org\/10.1093\/hmg\/ddp483","DOI":"10.1093\/hmg\/ddp483"},{"key":"3941_CR32","doi-asserted-by":"publisher","unstructured":"Goldman KN, Chenette D, Arju R, Duncan FE, Keefe DL, Grifo JA, et al. mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proc Natl Acad Sci U S A [Internet]. 2017;114:3186\u201391. Available from: https:\/\/doi.org\/10.1073\/pnas.1617233114","DOI":"10.1073\/pnas.1617233114"},{"key":"3941_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13697137.2017.1392501","volume":"21","author":"S Minooee","year":"2018","unstructured":"Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Prediction of age at menopause in women with polycystic ovary syndrome. Climacteric. 2018;21:29\u201334. https:\/\/doi.org\/10.1080\/13697137.2017.1392501.","journal-title":"Climacteric"},{"key":"3941_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/humupd\/dmv037","volume":"21","author":"H Zhang","year":"2015","unstructured":"Zhang H, Liu K. Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood. Hum Reprod Update. 2015;21:779\u201386. https:\/\/doi.org\/10.1093\/humupd\/dmv037.","journal-title":"Hum Reprod Update"},{"key":"3941_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41598-020-79488-4","volume":"11","author":"C Lliberos","year":"2021","unstructured":"Lliberos C, Liew SH, Zareie P, La Gruta NL, Mansell A, Hutt K. Evaluation of inflammation and follicle depletion during ovarian ageing in mice. Sci Rep. 2021;11:278. https:\/\/doi.org\/10.1038\/s41598-020-79488-4.","journal-title":"Sci Rep"},{"issue":"6","key":"3941_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41419-018-0633-7","volume":"9","author":"Q-N Nguyen","year":"2018","unstructured":"Nguyen Q-N, Zerafa N, Liew SH, Morgan FH, Strasser A, Scott CL, et al. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility. Cell Death Dis. 2018;9:618. https:\/\/doi.org\/10.1038\/s41419-018-0633-7.","journal-title":"Cell Death Dis"},{"key":"3941_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/molehr\/gaaa043","volume":"26","author":"KJ Szymanska","year":"2020","unstructured":"Szymanska KJ, Tan X, Oktay K. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging. Mol Hum Reprod. 2020;26:553\u201366. https:\/\/doi.org\/10.1093\/molehr\/gaaa043.","journal-title":"Mol Hum Reprod"},{"key":"3941_CR38","doi-asserted-by":"publisher","unstructured":"Wang S, Zheng Y, Li J, Yu Y, Zhang W, Song M, et al. Single-cell transcriptomic atlas of primate ovarian aging. Cell [Internet]. 2020;180:585\u2013600.e19. Available from: https:\/\/doi.org\/10.1016\/j.cell.2020.01.009","DOI":"10.1016\/j.cell.2020.01.009"},{"key":"3941_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.628473","volume":"8","author":"C Lliberos","year":"2020","unstructured":"Lliberos C, Liew SH, Mansell A, Hutt KJ. The inflammasome contributes to depletion of the ovarian reserve during aging in mice. Front Cell Dev Biol. 2020;8:628473. https:\/\/doi.org\/10.3389\/fcell.2020.628473.","journal-title":"Front Cell Dev Biol"},{"key":"3941_CR40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.18632\/aging.100363","volume":"3","author":"R Soleimani","year":"2011","unstructured":"Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY). 2011;3:782\u201393. https:\/\/doi.org\/10.18632\/aging.100363.","journal-title":"Aging (Albany NY)"},{"key":"3941_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","volume":"48","author":"JB Kerr","year":"2012","unstructured":"Kerr JB, Hutt KJ, Michalak EM, Cook M, Vandenberg CJ, Liew SH, et al. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol Cell. 2012;48:343\u201352. https:\/\/doi.org\/10.1016\/j.molcel.2012.08.017.","journal-title":"Mol Cell"},{"key":"3941_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/molehr\/gaz020","volume":"25","author":"QN Nguyen","year":"2019","unstructured":"Nguyen QN, Zerafa N, Liew SH, Findlay JK, Hickey M, Hutt KJ. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes. Mol Hum Reprod. 2019;25:433\u201344. https:\/\/doi.org\/10.1093\/molehr\/gaz020.","journal-title":"Mol Hum Reprod"},{"key":"3941_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1126\/science.1247671","volume":"343","author":"E Bolcun-Filas","year":"2014","unstructured":"Bolcun-Filas E, Rinaldi VD, White ME, Schimenti JC. Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. Science. 2014;343:533\u20136. https:\/\/doi.org\/10.1126\/science.1247671.","journal-title":"Science"},{"key":"3941_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/humupd\/7.6.535","volume":"7","author":"D Meirow","year":"2001","unstructured":"Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535\u201343. https:\/\/doi.org\/10.1093\/humupd\/7.6.535.","journal-title":"Hum Reprod Update"},{"key":"3941_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5:185ra62. https:\/\/doi.org\/10.1126\/scitranslmed.3005402.","journal-title":"Sci Transl Med"},{"key":"3941_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79643-x","volume":"11","author":"S Titus","year":"2021","unstructured":"Titus S, Szymanska KJ, Musul B, Turan V, Taylan E, Garcia-Milian R, et al. Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation. Sci Rep. 2021;11:407. https:\/\/doi.org\/10.1038\/s41598-020-79643-x.","journal-title":"Sci Rep"},{"key":"3941_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/humrep\/deaf024","volume":"40","author":"M Erden","year":"2025","unstructured":"Erden M, Oktay KH. Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles. Hum Reprod. 2025;40:571\u20139. https:\/\/doi.org\/10.1093\/humrep\/deaf024.","journal-title":"Hum Reprod"},{"key":"3941_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","volume":"34","author":"Y Lande","year":"2017","unstructured":"Lande Y, Fisch B, Tsur A, Farhi J, Prag-Rosenberg R, Ben-Haroush A, et al. Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro. Reprod Biomed Online. 2017;34:104\u201314. https:\/\/doi.org\/10.1016\/j.rbmo.2016.10.005.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216291","volume":"24","author":"O Kashi","year":"2023","unstructured":"Kashi O, Meirow D. Overactivation or apoptosis: which mechanisms affect chemotherapy-induced ovarian reserve depletion. Int J Mol Sci. 2023;24:16291. https:\/\/doi.org\/10.3390\/ijms242216291.","journal-title":"Int J Mol Sci"},{"key":"3941_CR50","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1096\/fj.201801089R","volume":"33","author":"C Sonigo","year":"2019","unstructured":"Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J. 2019;33:1278\u201387. https:\/\/doi.org\/10.1096\/fj.201801089R.","journal-title":"FASEB J"},{"key":"3941_CR51","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/humrep\/dead255","volume":"39","author":"R Rosario","year":"2024","unstructured":"Rosario R, Stewart HL, Spears N, Telfer EE, Anderson RA. Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro. Hum Reprod. 2024;39:382\u201392. https:\/\/doi.org\/10.1093\/humrep\/dead255.","journal-title":"Hum Reprod"},{"key":"3941_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gene.2013.03.039","volume":"523","author":"X-M Zhang","year":"2013","unstructured":"Zhang X-M, Li L, Xu J-J, Wang N, Liu W-J, Lin X-H, et al. Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression. Gene. 2013;523:82\u20137. https:\/\/doi.org\/10.1016\/j.gene.2013.03.039.","journal-title":"Gene"},{"key":"3941_CR53","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s10815-019-01507-9","volume":"36","author":"H Roness","year":"2019","unstructured":"Roness H, Spector I, Leichtmann-Bardoogo Y, Savino AM, Dereh-Haim S, Meirow D. Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects. J Assist Reprod Genet. 2019;36:1793\u2013803. https:\/\/doi.org\/10.1007\/s10815-019-01507-9.","journal-title":"J Assist Reprod Genet"},{"key":"3941_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s43032-023-01294-w","volume":"31","author":"Q Xie","year":"2024","unstructured":"Xie Q, Liao Q, Wang L, Zhang Y, Chen J, Bai H, et al. The dominant mechanism of cyclophosphamide-induced damage to ovarian reserve: premature activation or apoptosis of primordial follicles. Reprod Sci. 2024;31:30\u201344. https:\/\/doi.org\/10.1007\/s43032-023-01294-w.","journal-title":"Reprod Sci"},{"key":"3941_CR55","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","volume":"115","author":"D Shai","year":"2021","unstructured":"Shai D, Aviel-Ronen S, Spector I, Raanani H, Shapira M, Gat I, et al. Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss. Fertil Steril. 2021;115:1239\u201349. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.11.040.","journal-title":"Fertil Steril"},{"key":"3941_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/19396368.2012.751463","volume":"59","author":"L Detti","year":"2013","unstructured":"Detti L, Martin DC, Williams RW, Schlabritz-Loutsevich N, Williams LJ, Uhlmann RA. Somatic and reproductive outcomes in mice treated with cyclophosphamide in pre-pubertal age. Syst Biol Reprod Med. 2013;59:140\u20135. https:\/\/doi.org\/10.3109\/19396368.2012.751463.","journal-title":"Syst Biol Reprod Med"},{"key":"3941_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7273846","volume":"2021","author":"L He","year":"2021","unstructured":"He L, Long X, Yu N, Li Y, Liu X, Cheng X. Premature ovarian insufficiency (POI) induced by dynamic intensity modulated radiation therapy via P13K-AKT-FOXO3a in rat models. Biomed Res Int. 2021;2021:7273846. https:\/\/doi.org\/10.1155\/2021\/7273846.","journal-title":"Biomed Res Int"},{"key":"3941_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147484","volume":"22","author":"S Kim","year":"2021","unstructured":"Kim S, Kim S-W, Han S-J, Lee S, Park H-T, Song J-Y, et al. Molecular mechanism and prevention strategy of chemotherapy- and radiotherapy-induced ovarian damage. Int J Mol Sci. 2021;22:7484. https:\/\/doi.org\/10.3390\/ijms22147484.","journal-title":"Int J Mol Sci"},{"key":"3941_CR59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","volume":"18","author":"SS Faubion","year":"2015","unstructured":"Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18:483\u201391. https:\/\/doi.org\/10.3109\/13697137.2015.1020484.","journal-title":"Climacteric"},{"key":"3941_CR60","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1200\/JCO-24-02782","volume":"43","author":"HI Su","year":"2025","unstructured":"Su HI, Lacchetti C, Letourneau J, Partridge AH, Qamar R, Quinn GP, et al. Fertility preservation in people with cancer: ASCO guideline update. J Clin Oncol. 2025;43:1488\u2013515. https:\/\/doi.org\/10.1200\/JCO-24-02782.","journal-title":"J Clin Oncol"},{"key":"3941_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa052","volume":"2020","author":"RA Anderson","year":"2020","unstructured":"ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D\u2019Angelo A, Chuva de Sousa Lopes SM, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020:hoaa052. https:\/\/doi.org\/10.1093\/hropen\/hoaa052.","journal-title":"Hum Reprod Open"},{"key":"3941_CR62","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1200\/JCO.22.01885","volume":"41","author":"AC Reynolds","year":"2023","unstructured":"Reynolds AC, McKenzie LJ. Cancer treatment-related ovarian dysfunction in women of childbearing potential: management and fertility preservation options. J Clin Oncol. 2023;41:2281\u201392. https:\/\/doi.org\/10.1200\/JCO.22.01885.","journal-title":"J Clin Oncol"},{"key":"3941_CR63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3949\/ccjm.88gr.21001","volume":"88","author":"L Detti","year":"2021","unstructured":"Detti L. Options for preserving fertility in women undergoing gonadotoxic treatment. Cleve Clin J Med. 2021;88:607\u201312. https:\/\/doi.org\/10.3949\/ccjm.88gr.21001.","journal-title":"Cleve Clin J Med"},{"key":"3941_CR64","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","volume":"22","author":"RL Mulder","year":"2021","unstructured":"Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC, et al. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22:e45-56. https:\/\/doi.org\/10.1016\/S1470-2045(20)30594-5.","journal-title":"Lancet Oncol"},{"key":"3941_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184192","volume":"10","author":"L Arecco","year":"2021","unstructured":"Arecco L, Ruelle T, Martelli V, Boutros A, Latocca MM, Spinaci S, et al. How to protect ovarian function before and during chemotherapy? J Clin Med. 2021;10:4192. https:\/\/doi.org\/10.3390\/jcm10184192.","journal-title":"J Clin Med"},{"key":"3941_CR66","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.fertnstert.2025.08.017","volume":"124","author":"S Kalluru","year":"2025","unstructured":"Kalluru S, Vu M, Brady PC. Fertility preservation for cancer: referral guidelines, treatment options, and specific considerations. Fertil Steril. 2025;124:585\u201392. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.08.017.","journal-title":"Fertil Steril"},{"key":"3941_CR67","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.fertnstert.2013.08.041","volume":"100","author":"Ethics Committee of American Society for Reproductive Medicine","year":"2013","unstructured":"Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100:1224\u201331. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.041.","journal-title":"Fertil Steril"},{"key":"3941_CR68","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.fertnstert.2013.08.012","volume":"100","author":"Practice Committee of American Society for Reproductive Medicine","year":"2013","unstructured":"Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100:1214\u201323. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.012.","journal-title":"Fertil Steril"},{"key":"3941_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-025-01388-x","volume":"23","author":"NLA Emrich","year":"2025","unstructured":"Emrich NLA, Einenkel R, F\u00e4rber CM, Schallmoser A, S\u00e4nger N. Ovarian tissue cryopreservation for fertility preservation: a two-decade single-center experience with 451 children and adolescents. Reprod Biol Endocrinol. 2025;23:51. https:\/\/doi.org\/10.1186\/s12958-025-01388-x.","journal-title":"Reprod Biol Endocrinol"},{"key":"3941_CR70","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.fertnstert.2021.03.008","volume":"115","author":"M-M Dolmans","year":"2021","unstructured":"Dolmans M-M, von Wolff M, Poirot C, Diaz-Garcia C, Cacciottola L, Boissel N, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115:1102\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.03.008.","journal-title":"Fertil Steril"},{"key":"3941_CR71","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/humrep\/dex040","volume":"32","author":"P Jadoul","year":"2017","unstructured":"Jadoul P, Guilmain A, Squifflet J, Luyckx M, Votino R, Wyns C, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017;32:1046\u201354. https:\/\/doi.org\/10.1093\/humrep\/dex040.","journal-title":"Hum Reprod"},{"key":"3941_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hox001","volume":"2017","author":"RA Anderson","year":"2017","unstructured":"Anderson RA, Wallace WHB, Telfer EE. Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives. Hum Reprod Open. 2017;2017:hox001. https:\/\/doi.org\/10.1093\/hropen\/hox001.","journal-title":"Hum Reprod Open"},{"key":"3941_CR73","doi-asserted-by":"publisher","unstructured":"Grubliauskaite M, van der Perk MEM, Bos AME, Meijer AJM, Gudleviciene Z, van den Heuvel-Eibrink MM, et al. Minimal infiltrative disease identification in cryopreserved ovarian tissue of girls with cancer for future use: a systematic review. Cancers (Basel) [Internet]. 2023;15:4199. Available from: https:\/\/doi.org\/10.3390\/cancers15174199","DOI":"10.3390\/cancers15174199"},{"key":"3941_CR74","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1177\/1933719117737850","volume":"25","author":"L Detti","year":"2018","unstructured":"Detti L, Fletcher NM, Saed GM, Peregrin-Alvarez I, Uhlmann RA. Anti-m\u00fcllerian hormone (AMH) may stall ovarian cortex function through modulation of hormone receptors other than the AMH receptor. Reprod Sci. 2018;25:1218\u201323. https:\/\/doi.org\/10.1177\/1933719117737850.","journal-title":"Reprod Sci"},{"key":"3941_CR75","doi-asserted-by":"publisher","first-page":"F35","DOI":"10.1530\/REP-19-0097","volume":"158","author":"H Roness","year":"2019","unstructured":"Roness H, Meirow D. Fertility preservation: follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158:F35-44. https:\/\/doi.org\/10.1530\/REP-19-0097.","journal-title":"Reproduction"},{"key":"3941_CR76","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.rbmo.2021.06.019","volume":"43","author":"L Cacciottola","year":"2021","unstructured":"Cacciottola L, Donnez J, Dolmans M-M. Ovarian tissue damage after grafting: systematic review of strategies to improve follicle outcomes. Reprod Biomed Online. 2021;43:351\u201369. https:\/\/doi.org\/10.1016\/j.rbmo.2021.06.019.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR77","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/humrep\/dex218","volume":"32","author":"F Martinez","year":"2015","unstructured":"Martinez F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Hum Reprod. 2015;32:1802\u201311. https:\/\/doi.org\/10.1093\/humrep\/dex218.","journal-title":"Hum Reprod"},{"key":"3941_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008018.pub3","volume":"3","author":"H Chen","year":"2019","unstructured":"Chen H, Xiao L, Li J, Cui L, Huang W. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2019;3:CD008018. https:\/\/doi.org\/10.1002\/14651858.CD008018.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"3941_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042287","volume":"23","author":"G Valsamakis","year":"2022","unstructured":"Valsamakis G, Valtetsiotis K, Charmandari E, Lambrinoudaki I, Vlahos NF. GnRH analogues as a co-treatment to therapy in women of reproductive age with cancer and fertility preservation. Int J Mol Sci. 2022;23:2287. https:\/\/doi.org\/10.3390\/ijms23042287.","journal-title":"Int J Mol Sci"},{"key":"3941_CR80","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/1744666X.2020.1724091","volume":"16","author":"S-N Luong","year":"2020","unstructured":"Luong S-N, Isaacs A, Liu Z, Sin FE, Giles I. A systematic review and meta-analysis of the gonadotoxic effects of cyclophosphamide and benefits of gonadotropin releasing hormone agonists (GnRHa) in women of child-bearing age with autoimmune rheumatic disease. Expert Rev Clin Immunol. 2020;16:321\u201333. https:\/\/doi.org\/10.1080\/1744666X.2020.1724091.","journal-title":"Expert Rev Clin Immunol"},{"key":"3941_CR81","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1177\/09612033221128740","volume":"31","author":"K Ejaz","year":"2022","unstructured":"Ejaz K, Abid D, Juneau P, Chu J, Hasni S. Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: a meta-analysis. Lupus. 2022;31:1706\u201313. https:\/\/doi.org\/10.1177\/09612033221128740.","journal-title":"Lupus"},{"key":"3941_CR82","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","volume":"36","author":"M Lambertini","year":"2018","unstructured":"Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol. 2018;36:1981\u201390. https:\/\/doi.org\/10.1200\/JCO.2018.78.0858.","journal-title":"J Clin Oncol"},{"key":"3941_CR83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72:529\u201356. https:\/\/doi.org\/10.1002\/art.41191.","journal-title":"Arthritis Rheumatol"},{"key":"3941_CR84","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1413204","volume":"372","author":"HCF Moore","year":"2015","unstructured":"Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372:923\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1413204.","journal-title":"N Engl J Med"},{"issue":"4","key":"3941_CR85","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.fertnstert.2013.12.028","volume":"101","author":"L Detti","year":"2014","unstructured":"Detti L, Uhlmann RA, Zhang J, Diamond MP, Saed GM, Fletcher NM, et al. Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice. Fertil Steril. 2014;101(4):1157. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.028.","journal-title":"Fertil Steril"},{"key":"3941_CR86","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s10815-025-03473-x","volume":"42","author":"L Detti","year":"2025","unstructured":"Detti L, Mari MC, Diamond MP, Saed GM. Anti-Mullerian hormone (AMH) protects ovarian follicle loss by downregulating granulosa cell function in in vitro and in vivo models. J Assist Reprod Genet. 2025;42:2029\u201337. https:\/\/doi.org\/10.1007\/s10815-025-03473-x.","journal-title":"J Assist Reprod Genet"},{"key":"3941_CR87","doi-asserted-by":"publisher","unstructured":"Detti L, Abuzeid MI, Peregrin-Alvarez I, Christiansen ME, Malekzadeh P, Sledge J, et al. Recombinant anti-m\u00fcllerian hormone (rAMH) for stalling in vitro granulosa cell replication. Reprod Sci [Internet]. 2020;27:1873\u20138. Available from: https:\/\/doi.org\/10.1007\/s43032-020-00206-6","DOI":"10.1007\/s43032-020-00206-6"},{"key":"3941_CR88","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.rbmo.2020.10.001","volume":"42","author":"J Huang","year":"2021","unstructured":"Huang J, Shan W, Li N, Zhou B, Guo E, Xia M, et al. Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice. Reprod Biomed Online. 2021;42:505\u201319. https:\/\/doi.org\/10.1016\/j.rbmo.2020.10.001.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR89","doi-asserted-by":"publisher","unstructured":"Huang C-C, Chou C-H, Yang Y-S, Ho H-N, Shun C-T, Wen W-F, et al. Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy. Mol Hum Reprod [Internet]. 2021;27. Available from: https:\/\/doi.org\/10.1093\/molehr\/gaaa084","DOI":"10.1093\/molehr\/gaaa084"},{"key":"3941_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01572-4","volume":"17","author":"N Zatalian","year":"2024","unstructured":"Zatalian N, Dalman A, Afsharian P, Hezavehei M, Gourabi H. Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K\/Akt\/mTOR signaling pathway and Yap-1. J Ovarian Res. 2024;17:251. https:\/\/doi.org\/10.1186\/s13048-024-01572-4.","journal-title":"J Ovarian Res"},{"key":"3941_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157314","volume":"26","author":"W Zaj\u0105czkowska","year":"2025","unstructured":"Zaj\u0105czkowska W, Buda M, K\u0119dzia W, Kapczuk K. Fertility protection in female cancer patients: from molecular mechanisms of gonadotoxic therapies to pharmacotherapeutic possibilities. Int J Mol Sci. 2025;26:7314. https:\/\/doi.org\/10.3390\/ijms26157314.","journal-title":"Int J Mol Sci"},{"key":"3941_CR92","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.rbmo.2021.08.003","volume":"44","author":"C-N Chen","year":"2022","unstructured":"Chen C-N, Chang L-T, Chen C-H, Tam K-W. Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis. Reprod Biomed Online. 2022;44:357\u201369. https:\/\/doi.org\/10.1016\/j.rbmo.2021.08.003.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00743-y","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Long H, Cong Y, Gao H, Lyu Q, Yu S, et al. Quercetin prevents primordial follicle loss via suppression of PI3K\/Akt\/Foxo3a pathway activation in cyclophosphamide-treated mice. Reprod Biol Endocrinol. 2021;19:63. https:\/\/doi.org\/10.1186\/s12958-021-00743-y.","journal-title":"Reprod Biol Endocrinol"},{"key":"3941_CR94","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0960327114564793","volume":"34","author":"HS Saleh","year":"2015","unstructured":"Saleh HS, Omar E, Froemming GRA, Said RM. Tocotrienol preserves ovarian function in cyclophosphamide therapy. Hum Exp Toxicol. 2015;34:946\u201352. https:\/\/doi.org\/10.1177\/0960327114564793.","journal-title":"Hum Exp Toxicol"},{"key":"3941_CR95","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00210-019-01662-x","volume":"392","author":"RS Said","year":"2019","unstructured":"Said RS, Mantawy EM, El-Demerdash E. Mechanistic perspective of protective effects of resveratrol against cisplatin-induced ovarian injury in rats: emphasis on anti-inflammatory and anti-apoptotic effects. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:1225\u201338. https:\/\/doi.org\/10.1007\/s00210-019-01662-x.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3941_CR96","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/humrep\/deae085","volume":"39","author":"Y Tanaka","year":"2024","unstructured":"Tanaka Y, Amano T, Nakamura A, Yoshino F, Takebayashi A, Takahashi A, et al. Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model. Hum Reprod. 2024;39:1519\u201332. https:\/\/doi.org\/10.1093\/humrep\/deae085.","journal-title":"Hum Reprod"},{"key":"3941_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-017-0350-3","volume":"10","author":"L Zhou","year":"2017","unstructured":"Zhou L, Xie Y, Li S, Liang Y, Qiu Q, Lin H, et al. Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo. J Ovarian Res. 2017;10:56. https:\/\/doi.org\/10.1186\/s13048-017-0350-3.","journal-title":"J Ovarian Res"},{"key":"3941_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105189","volume":"25","author":"N Cortez","year":"2024","unstructured":"Cortez N, Villegas C, Burgos V, Ortiz L, Cabrera-Pardo JR, Paz C. Therapeutic potential of chlorogenic acid in chemoresistance and chemoprotection in cancer treatment. Int J Mol Sci. 2024;25:5189. https:\/\/doi.org\/10.3390\/ijms25105189.","journal-title":"Int J Mol Sci"},{"key":"3941_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00659-z","volume":"18","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhang S, Chen L, Liu X, Su H, Chen L, et al. Sphingosine 1-phosphate protects against radiation-induced ovarian injury in female rats-impact on mitochondrial-related genes. Reprod Biol Endocrinol. 2020;18:99. https:\/\/doi.org\/10.1186\/s12958-020-00659-z.","journal-title":"Reprod Biol Endocrinol"},{"key":"3941_CR100","doi-asserted-by":"publisher","unstructured":"Gai Y, Wu W, Wang H, Li Y, Li C, Wang Y, et al. Silibinin attenuates 3-nitropropionic acid-induced ovarian toxicity by alleviating oxidative stress and granulosa cell apoptosis. Reprod Toxicol [Internet]. 2025;137:109027. Available from: https:\/\/doi.org\/10.1016\/j.reprotox.2025.109027","DOI":"10.1016\/j.reprotox.2025.109027"},{"key":"3941_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/srep23120","volume":"6","author":"G-Y Xiao","year":"2016","unstructured":"Xiao G-Y, Cheng C-C, Chiang Y-S, Cheng W-K, Liu I-H, Wu S-C. Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy. Sci Rep. 2016;6:23120. https:\/\/doi.org\/10.1038\/srep23120.","journal-title":"Sci Rep"},{"key":"3941_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12432","author":"H Jang","year":"2017","unstructured":"Jang H, Na Y, Hong K, Lee S, Moon S, Cho M, et al. Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles. J Pineal Res. 2017. https:\/\/doi.org\/10.1111\/jpi.12432.","journal-title":"J Pineal Res"},{"key":"3941_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/cdd.2016.97","volume":"24","author":"V Rossi","year":"2017","unstructured":"Rossi V, Lispi M, Longobardi S, Mattei M, Di Rella F, Salustri A, et al. LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse. Cell Death Differ. 2017;24:72\u201382. https:\/\/doi.org\/10.1038\/cdd.2016.97.","journal-title":"Cell Death Differ"},{"key":"3941_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071208","volume":"11","author":"S Marcozzi","year":"2022","unstructured":"Marcozzi S, Ciccosanti F, Fimia GM, Piacentini M, Caggiano C, Sette C, et al. Analysis of secreted proteins from prepubertal ovarian tissues exposed in vitro to cisplatin and LH. Cells. 2022;11:1208. https:\/\/doi.org\/10.3390\/cells11071208.","journal-title":"Cells"},{"key":"3941_CR105","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/humrep\/deab165","volume":"36","author":"LM Del Castillo","year":"2021","unstructured":"Del Castillo LM, Buigues A, Rossi V, Soriano MJ, Martinez J, De Felici M, et al. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model. Hum Reprod. 2021;36:2514\u201328. https:\/\/doi.org\/10.1093\/humrep\/deab165.","journal-title":"Hum Reprod"},{"key":"3941_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.723388","volume":"9","author":"W-X Liu","year":"2021","unstructured":"Liu W-X, Zhang Y-J, Wang Y-F, Klinger FG, Tan S-J, Farini D, et al. Protective mechanism of luteinizing hormone and follicle-stimulating hormone against nicotine-induced damage of mouse early folliculogenesis. Front Cell Dev Biol. 2021;9:723388. https:\/\/doi.org\/10.3389\/fcell.2021.723388.","journal-title":"Front Cell Dev Biol"},{"key":"3941_CR107","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/humupd\/dmae020","volume":"30","author":"Y Guo","year":"2024","unstructured":"Guo Y, Xue L, Tang W, Xiong J, Chen D, Dai Y, et al. Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage. Hum Reprod Update. 2024;30:614\u201347. https:\/\/doi.org\/10.1093\/humupd\/dmae020.","journal-title":"Hum Reprod Update"},{"key":"3941_CR108","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-x","volume":"45","author":"RL Cate","year":"1986","unstructured":"Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, et al. Isolation of the bovine and human genes for m\u00fcllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45:685\u201398. https:\/\/doi.org\/10.1016\/0092-8674(86)90783-x.","journal-title":"Cell"},{"key":"3941_CR109","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnab012","volume":"42","author":"N di Clemente","year":"2021","unstructured":"di Clemente N, Racine C, Pierre A, Taieb J. Anti-M\u00fcllerian hormone in female reproduction. Endocr Rev. 2021;42:753\u201382. https:\/\/doi.org\/10.1210\/endrev\/bnab012.","journal-title":"Endocr Rev"},{"key":"3941_CR110","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"ALL Durlinger","year":"2002","unstructured":"Durlinger ALL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-M\u00fcllerian hormone. Reproduction. 2002;124:601\u20139. https:\/\/doi.org\/10.1530\/rep.0.1240601.","journal-title":"Reproduction"},{"key":"3941_CR111","doi-asserted-by":"publisher","unstructured":"Cohen-Haguenauer O, Picard JY, Matt\u00e9i M-G, Serero S, Van Cong N, de Tand M-F, et al. Mapping of the gene for anti-M\u00fcllerian hormone to the short arm of human chromosome 19. Cytogenet Genome Res [Internet]. 1987;44:2\u20136. Available from: https:\/\/doi.org\/10.1159\/000132332","DOI":"10.1159\/000132332"},{"key":"3941_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101634","volume":"36","author":"N Josso","year":"2022","unstructured":"Josso N, Picard J-Y. Genetics of anti-M\u00fcllerian hormone and its signaling pathway. Best Pract Res Clin Endocrinol Metab. 2022;36:101634. https:\/\/doi.org\/10.1016\/j.beem.2022.101634.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3941_CR113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104809118","volume":"118","author":"KN Hart","year":"2021","unstructured":"Hart KN, Stocker WA, Nagykery NG, Walton KL, Harrison CA, Donahoe PK, et al. Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-\u03b2 family. Proc Natl Acad Sci U S A. 2021;118:e2104809118. https:\/\/doi.org\/10.1073\/pnas.2104809118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3941_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.927824","volume":"13","author":"JA Howard","year":"2022","unstructured":"Howard JA, Hart KN, Thompson TB. Molecular mechanisms of AMH signaling. Front Endocrinol (Lausanne). 2022;13:927824. https:\/\/doi.org\/10.3389\/fendo.2022.927824.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3941_CR115","doi-asserted-by":"publisher","unstructured":"Tsukamoto S, Mizuta T, Fujimoto M, Ohte S, Osawa K, Miyamoto A, et al. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Sci Rep [Internet]. 2014;4:7596. Available from: https:\/\/doi.org\/10.1038\/srep07596","DOI":"10.1038\/srep07596"},{"key":"3941_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081551","volume":"8","author":"L S\u00e8des","year":"2013","unstructured":"S\u00e8des L, Leclerc A, Moindjie H, Cate RL, Picard J-Y, di Clemente N, et al. Anti-M\u00fcllerian hormone recruits BMPR-IA in immature granulosa cells. PLoS One. 2013;8:e81551. https:\/\/doi.org\/10.1371\/journal.pone.0081551.","journal-title":"PLoS One"},{"key":"3941_CR117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s1043-2760(03)00005-5","volume":"14","author":"N Josso","year":"2003","unstructured":"Josso N, Clemente N. Transduction pathway of anti-M\u00fcllerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol Metab. 2003;14:91\u20137. https:\/\/doi.org\/10.1016\/s1043-2760(03)00005-5.","journal-title":"Trends Endocrinol Metab"},{"key":"3941_CR118","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022137","author":"K Luo","year":"2017","unstructured":"Luo K. Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways. Cold Spring Harb Perspect Biol. 2017. https:\/\/doi.org\/10.1101\/cshperspect.a022137.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3941_CR119","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/rep.1.01074","volume":"132","author":"PG Knight","year":"2006","unstructured":"Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006;132:191\u2013206. https:\/\/doi.org\/10.1530\/rep.1.01074.","journal-title":"Reproduction"},{"key":"3941_CR120","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7827-4-21","volume":"4","author":"N Kaivo-oja","year":"2006","unstructured":"Kaivo-oja N, Jeffery LA, Ritvos O, Mottershead DG. Smad signalling in the ovary. Reprod Biol Endocrinol. 2006;4:21. https:\/\/doi.org\/10.1186\/1477-7827-4-21.","journal-title":"Reprod Biol Endocrinol"},{"key":"3941_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/biom16010130","volume":"16","author":"N Bertani","year":"2026","unstructured":"Bertani N, Alteri A, Cacciottola L, D\u2019Addato G, La Sala G, Lozanoska-Ochser B, et al. TGF-\u03b2 signaling in the pathophysiology of the ovary: a double-edged regulator. Biomolecules. 2026;16:130. https:\/\/doi.org\/10.3390\/biom16010130.","journal-title":"Biomolecules"},{"key":"3941_CR122","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2011.04.024","volume":"359","author":"PG Knight","year":"2012","unstructured":"Knight PG, Satchell L, Glister C. Intra-ovarian roles of activins and inhibins. Mol Cell Endocrinol. 2012;359:53\u201365. https:\/\/doi.org\/10.1016\/j.mce.2011.04.024.","journal-title":"Mol Cell Endocrinol"},{"key":"3941_CR123","doi-asserted-by":"publisher","unstructured":"Appiah Adu-Gyamfi E, Tanam Djankpa F, Nelson W, Czika A, Kumar Sah S, Lamptey J, et al. Activin and inhibin signaling: from regulation of physiology to involvement in the pathology of the female reproductive system. Cytokine [Internet]. 2020;133:155105. Available from: https:\/\/doi.org\/10.1016\/j.cyto.2020.155105","DOI":"10.1016\/j.cyto.2020.155105"},{"key":"3941_CR124","doi-asserted-by":"publisher","unstructured":"Nguyen NMP, Mermin-Bunnell AM, Mattos K, Cleverdon J, Kano M, Chauvin M, et al. Anti-M\u00fcllerian hormone ameliorates uterine DNA damage response and prevents pregnancy complications in doxorubicin-treated mice. Biol Reprod [Internet]. 2025; Available from: https:\/\/doi.org\/10.1093\/biolre\/ioaf233","DOI":"10.1093\/biolre\/ioaf233"},{"key":"3941_CR125","doi-asserted-by":"publisher","unstructured":"Garrel G, Racine C, L\u2019H\u00f4te D, Denoyelle C, Guigon CJ, di Clemente N, et al. Anti-M\u00fcllerian hormone: a new actor of sexual dimorphism in pituitary gonadotrope activity before puberty. Sci Rep [Internet]. 2016;6:23790. Available from: https:\/\/doi.org\/10.1038\/srep23790","DOI":"10.1038\/srep23790"},{"key":"3941_CR126","doi-asserted-by":"publisher","unstructured":"Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun [Internet]. 2016;7:10055. Available from: https:\/\/doi.org\/10.1038\/ncomms10055","DOI":"10.1038\/ncomms10055"},{"key":"3941_CR127","doi-asserted-by":"publisher","unstructured":"Paganoni AJJ, Cannarella R, Oleari R, Amoruso F, Antal R, Ruzza M, et al. Insulin-like growth factor 1, growth hormone, and anti-M\u00fcllerian hormone receptors are differentially expressed during GnRH neuron development. Int J Mol Sci [Internet]. 2023;24:13073. Available from: https:\/\/doi.org\/10.3390\/ijms241713073","DOI":"10.3390\/ijms241713073"},{"key":"3941_CR128","doi-asserted-by":"publisher","unstructured":"Cannarella R, Paganoni AJJ, Cicolari S, Oleari R, Condorelli RA, La Vignera S, et al. Anti-M\u00fcllerian hormone, growth hormone, and insulin-like growth factor 1 modulate the migratory and secretory patterns of GnRH neurons. Int J Mol Sci [Internet]. 2021;22:2445. Available from: https:\/\/doi.org\/10.3390\/ijms22052445","DOI":"10.3390\/ijms22052445"},{"key":"3941_CR129","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/09513590.2021.1950134","volume":"37","author":"A Oride","year":"2021","unstructured":"Oride A, Kanasaki H, Tumurbaatar T, Tumurgan Z, Okada H, Kyo S. Effect of anti-M\u00fcllerian hormone in hypothalamic Kiss-1- and GnRH-producing cell models. Gynecol Endocrinol. 2021;37:841\u20137. https:\/\/doi.org\/10.1080\/09513590.2021.1950134.","journal-title":"Gynecol Endocrinol"},{"key":"3941_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159112","volume":"11","author":"H Jin","year":"2016","unstructured":"Jin H, Won M, Park SE, Lee S, Park M, Bae J. FOXL2 is an essential activator of SF-1-induced transcriptional regulation of anti-M\u00fcllerian hormone in human granulosa cells. PLoS One. 2016;11:e0159112. https:\/\/doi.org\/10.1371\/journal.pone.0159112.","journal-title":"PLoS One"},{"key":"3941_CR131","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/mrd.20208","volume":"70","author":"NA Salmon","year":"2005","unstructured":"Salmon NA, Handyside AH, Joyce IM. Expression of Sox8, Sf1, Gata4, Wt1, Dax1, and Fog2 in the mouse ovarian follicle: implications for the regulation of Amh expression. Mol Reprod Dev. 2005;70:271\u20137. https:\/\/doi.org\/10.1002\/mrd.20208.","journal-title":"Mol Reprod Dev"},{"key":"3941_CR132","doi-asserted-by":"publisher","unstructured":"Roy S, Gandra D, Seger C, Biswas A, Kushnir VA, Gleicher N, et al. Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3K27AC in granulosa cells. Endocrinology [Internet]. 2018;159:3433\u201345. Available from: https:\/\/doi.org\/10.1210\/en.2018-00609","DOI":"10.1210\/en.2018-00609"},{"key":"3941_CR133","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/biolre\/ioy172","volume":"100","author":"C Qin","year":"2019","unstructured":"Qin C, Xia X, Fan Y, Jiang Y, Chen Y, Zhang N, et al. A novel, noncoding-RNA-mediated, post-transcriptional mechanism of anti-M\u00fcllerian hormone regulation by the H19\/let-7 axis. Biol Reprod. 2019;100:101\u201311. https:\/\/doi.org\/10.1093\/biolre\/ioy172.","journal-title":"Biol Reprod"},{"key":"3941_CR134","doi-asserted-by":"publisher","unstructured":"Kallen AN, Zhou X-B, Xu J, Qiao C, Ma J, Yan L, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell [Internet]. 2013;52:101\u201312. Available from: https:\/\/doi.org\/10.1016\/j.molcel.2013.08.027","DOI":"10.1016\/j.molcel.2013.08.027"},{"key":"3941_CR135","doi-asserted-by":"publisher","unstructured":"Pierre A, Peign\u00e9 M, Grynberg M, Arouche N, Taieb J, Hesters L, et al. Loss of LH-induced down-regulation of anti-M\u00fcllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Hum Reprod [Internet]. 2013;28:762\u20139. Available from: https:\/\/doi.org\/10.1093\/humrep\/des460","DOI":"10.1093\/humrep\/des460"},{"key":"3941_CR136","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/humrep\/dev042","volume":"30","author":"B Alvaro Mercadal","year":"2015","unstructured":"Alvaro Mercadal B, Imbert R, Demeestere I, Gervy C, De Leener A, Englert Y, et al. AMH mutations with reduced in vitro bioactivity are related to premature ovarian insufficiency. Hum Reprod. 2015;30:1196\u2013202. https:\/\/doi.org\/10.1093\/humrep\/dev042.","journal-title":"Hum Reprod"},{"key":"3941_CR137","doi-asserted-by":"publisher","first-page":"E473","DOI":"10.1210\/jc.2010-1799","volume":"96","author":"M Voorhuis","year":"2011","unstructured":"Voorhuis M, Broekmans FJ, Fauser BCJM, Onland-Moret NC, van der Schouw YT. Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab. 2011;96:E473-9. https:\/\/doi.org\/10.1210\/jc.2010-1799.","journal-title":"J Clin Endocrinol Metab"},{"key":"3941_CR138","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.rbmo.2019.04.010","volume":"39","author":"R Cheng","year":"2019","unstructured":"Cheng R, Xiong W, Luo X, Ma Y, Nie Y, Qiao X, et al. Association of gene polymorphisms in the anti-M\u00fcllerian hormone signalling pathway with ovarian function: a systematic review and meta-analysis. Reprod Biomed Online. 2019;39:513\u201321. https:\/\/doi.org\/10.1016\/j.rbmo.2019.04.010.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR139","doi-asserted-by":"publisher","first-page":"F81","DOI":"10.1530\/REP-18-0602","volume":"158","author":"N Josso","year":"2019","unstructured":"Josso N. Women in reproductive science: anti-M\u00fcllerian hormone: a look back and ahead. J Reprod Fertil. 2019;158:F81-9. https:\/\/doi.org\/10.1530\/REP-18-0602.","journal-title":"J Reprod Fertil"},{"key":"3941_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1468364","volume":"15","author":"M Gowkielewicz","year":"2024","unstructured":"Gowkielewicz M, Lipka A, Zdanowski W, Wa\u015bniewski T, Majewska M, Carlberg C. Anti-M\u00fcllerian hormone: biology and role in endocrinology and cancers. Front Endocrinol (Lausanne). 2024;15:1468364. https:\/\/doi.org\/10.3389\/fendo.2024.1468364.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3941_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11237209","volume":"11","author":"N Russell","year":"2022","unstructured":"Russell N, Gilmore A, Roudebush WE. Clinical utilities of anti-M\u00fcllerian hormone. J Clin Med. 2022;11:7209. https:\/\/doi.org\/10.3390\/jcm11237209.","journal-title":"J Clin Med"},{"key":"3941_CR142","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1210\/jc.2011-1502","volume":"96","author":"T Kuiri-H\u00e4nninen","year":"2011","unstructured":"Kuiri-H\u00e4nninen T, Kallio S, Seuri R, Tyrv\u00e4inen E, Liakka A, Tapanainen J, et al. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J Clin Endocrinol Metab. 2011;96:3432\u20139. https:\/\/doi.org\/10.1210\/jc.2011-1502.","journal-title":"J Clin Endocrinol Metab"},{"key":"3941_CR143","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1210\/jcem.84.10.6047","volume":"84","author":"E Rajpert-De Meyts","year":"1999","unstructured":"Rajpert-De Meyts E, J\u00f8rgensen N, Graem N, M\u00fcller J, Cate RL, Skakkebaek NE. Expression of anti-M\u00fcllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab. 1999;84:3836\u201344. https:\/\/doi.org\/10.1210\/jcem.84.10.6047.","journal-title":"J Clin Endocrinol Metab"},{"key":"3941_CR144","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/19396368.2018.1537385","volume":"65","author":"L Detti","year":"2019","unstructured":"Detti L, Christiansen ME, Francillon L, Ikuwezunma G, Diamond MP, Mari G, et al. Serum anti-M\u00fcllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses. Syst Biol Reprod Med. 2019;65:147\u201354. https:\/\/doi.org\/10.1080\/19396368.2018.1537385.","journal-title":"Syst Biol Reprod Med"},{"key":"3941_CR145","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/molehr\/gat024","volume":"19","author":"JV Jeppesen","year":"2013","unstructured":"Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19:519\u201327. https:\/\/doi.org\/10.1093\/molehr\/gat024.","journal-title":"Mol Hum Reprod"},{"key":"3941_CR146","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.rbmo.2012.01.023","volume":"24","author":"A Kedem-Dickman","year":"2012","unstructured":"Kedem-Dickman A, Maman E, Yung Y, Yerushalmi GM, Hemi R, Hanochi M, et al. Anti-M\u00fcllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes. Reprod Biomed Online. 2012;24:540\u20136. https:\/\/doi.org\/10.1016\/j.rbmo.2012.01.023.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR147","doi-asserted-by":"publisher","unstructured":"ACOG committee opinion no. 773: The use of antim\u00fcllerian hormone in women not seeking fertility care. Obstet Gynecol [Internet]. 2019;133:e274\u20138. Available from: https:\/\/doi.org\/10.1097\/AOG.0000000000003162","DOI":"10.1097\/AOG.0000000000003162"},{"key":"3941_CR148","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.fertnstert.2015.08.027","volume":"104","author":"C Gnoth","year":"2015","unstructured":"Gnoth C, Roos J, Broomhead D, Schiffner J, Godehardt E, Freundl G, et al. Antim\u00fcllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation day. Fertil Steril. 2015;104:1535-43.e1-4. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.08.027.","journal-title":"Fertil Steril"},{"key":"3941_CR149","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/humrep\/deu142","volume":"29","author":"KA Kissell","year":"2014","unstructured":"Kissell KA, Danaher MR, Schisterman EF, Wactawski-Wende J, Ahrens KA, Schliep K, et al. Biological variability in serum anti-M\u00fcllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod. 2014;29:1764\u201372. https:\/\/doi.org\/10.1093\/humrep\/deu142.","journal-title":"Hum Reprod"},{"key":"3941_CR150","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/humrep\/dep210","volume":"24","author":"A La Marca","year":"2009","unstructured":"La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS, ESHRE Special Interest Group for Reproductive Endocrinology- -AMH Round Table. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod. 2009;24:2264\u201375. https:\/\/doi.org\/10.1093\/humrep\/dep210.","journal-title":"Hum Reprod"},{"key":"3941_CR151","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA. Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361\u201373. https:\/\/doi.org\/10.1210\/clinem\/dgaa513.","journal-title":"J Clin Endocrinol Metab"},{"key":"3941_CR152","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12020-025-04265-0","volume":"89","author":"E Karaviti","year":"2025","unstructured":"Karaviti E, Karaviti D, Kani E-R, Chatziandreou E, Paschou SA, Psaltopoulou T, et al. The role of anti-M\u00fcllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction. Endocrine. 2025;89:338\u201355. https:\/\/doi.org\/10.1007\/s12020-025-04265-0.","journal-title":"Endocrine"},{"key":"3941_CR153","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","volume":"140","author":"AL Durlinger","year":"1999","unstructured":"Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mu\u0308llerian hormone in the mouse ovary1. Endocrinology. 1999;140:5789\u201396. https:\/\/doi.org\/10.1210\/endo.140.12.7204.","journal-title":"Endocrinology"},{"key":"3941_CR154","doi-asserted-by":"publisher","unstructured":"Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology [Internet]. 2002;143:1076\u201384. Available from: https:\/\/doi.org\/10.1210\/endo.143.3.8691","DOI":"10.1210\/endo.143.3.8691"},{"key":"3941_CR155","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/humupd\/dmm040","volume":"14","author":"RB Gilchrist","year":"2008","unstructured":"Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update. 2008;14:159\u201377. https:\/\/doi.org\/10.1093\/humupd\/dmm040.","journal-title":"Hum Reprod Update"},{"key":"3941_CR156","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2004.09.008","volume":"234","author":"JA Visser","year":"2005","unstructured":"Visser JA, Themmen APN. Anti-M\u00fcllerian hormone and folliculogenesis. Mol Cell Endocrinol. 2005;234:81\u20136. https:\/\/doi.org\/10.1016\/j.mce.2004.09.008.","journal-title":"Mol Cell Endocrinol"},{"key":"3941_CR157","doi-asserted-by":"publisher","unstructured":"Detti L, Fletcher NM, Saed GM, Sweatman TW, Uhlmann RA, Pappo A, et al. Xenotransplantation of pre-pubertal ovarian cortex and prevention of follicle depletion with anti-M\u00fcllerian hormone (AMH). J Assist Reprod Genet [Internet]. 2018;35:1831\u201341. Available from: https:\/\/doi.org\/10.1007\/s10815-018-1260-z","DOI":"10.1007\/s10815-018-1260-z"},{"key":"3941_CR158","unstructured":"Detti L. Anti-M\u00fcllerian hormone ( AMH ) and its multiple purposes in fertility preservation. 2019. Available from: https:\/\/api.semanticscholar.org\/CorpusID:111376628"},{"key":"3941_CR159","doi-asserted-by":"publisher","unstructured":"Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, et al. AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A [Internet]. 2017;114:E1688\u201397. Available from: https:\/\/doi.org\/10.1073\/pnas.1620729114","DOI":"10.1073\/pnas.1620729114"},{"key":"3941_CR160","doi-asserted-by":"publisher","first-page":"249","DOI":"10.23736\/S0026-4784.19.04276-X","volume":"71","author":"L Detti","year":"2019","unstructured":"Detti L, Fletcher NM, Uhlmann RA, Peregrin-Alvarez I, Roman RA, Saed GM. Anti-M\u00fcllerian hormone (AMH) regulates stemness-promoting factors in fresh and previously vitrified-warmed ovarian cortex. Minerva Ginecol. 2019;71:249\u201353. https:\/\/doi.org\/10.23736\/S0026-4784.19.04276-X.","journal-title":"Minerva Ginecol"},{"key":"3941_CR161","doi-asserted-by":"publisher","unstructured":"Zhang Q, Sun H, Jiang Y, Ding L, Wu S, Fang T, et al. MicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIA. PLoS One [Internet]. 2013;8:e59667. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0059667","DOI":"10.1371\/journal.pone.0059667"},{"key":"3941_CR162","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/09513590.2020.1828328","volume":"37","author":"I Peregrin-Alvarez","year":"2021","unstructured":"Peregrin-Alvarez I, Fletcher NM, Saed GM, Roman RA, Detti L. Anti-M\u00fcllerian hormone (AMH) regulates BRCA1 and BRCA2 gene expression after ovarian cortex transplantation. Gynecol Endocrinol. 2021;37:349\u201352. https:\/\/doi.org\/10.1080\/09513590.2020.1828328.","journal-title":"Gynecol Endocrinol"},{"key":"3941_CR163","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2414734122","volume":"122","author":"NMP Nguyen","year":"2025","unstructured":"Nguyen NMP, Chang EM, Chauvin M, Sicher N, Kashiwagi A, Nagykery N, et al. AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage. Proc Natl Acad Sci U S A. 2025;122:e2414734122. https:\/\/doi.org\/10.1073\/pnas.2414734122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3941_CR164","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1210\/en.2012-1158","volume":"153","author":"BK Campbell","year":"2012","unstructured":"Campbell BK, Clinton M, Webb R. The role of anti-M\u00fcllerian hormone (AMH) during follicle development in a monovulatory species (sheep). Endocrinology. 2012;153:4533\u201343. https:\/\/doi.org\/10.1210\/en.2012-1158.","journal-title":"Endocrinology"},{"key":"3941_CR165","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1095\/biolreprod64.1.293","volume":"64","author":"EA McGee","year":"2001","unstructured":"McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H, Hsueh AJ. M\u00fcllerian inhibitory substance induces growth of rat preantral ovarian follicles1. Biol Reprod. 2001;64:293\u20138. https:\/\/doi.org\/10.1095\/biolreprod64.1.293.","journal-title":"Biol Reprod"},{"key":"3941_CR166","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2004.12.010","volume":"234","author":"KLT Schmidt","year":"2005","unstructured":"Schmidt KLT, Kryger-Baggesen N, Byskov AG, Andersen CY. Anti-M\u00fcllerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol. 2005;234:87\u201393. https:\/\/doi.org\/10.1016\/j.mce.2004.12.010.","journal-title":"Mol Cell Endocrinol"},{"key":"3941_CR167","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/JOE-18-0005","volume":"237","author":"MW Pankhurst","year":"2018","unstructured":"Pankhurst MW, Kelley RL, Sanders RL, Woodcock SR, Oorschot DE, Batchelor NJ. Anti-M\u00fcllerian hormone overexpression restricts preantral ovarian follicle survival. J Endocrinol. 2018;237:153\u201363. https:\/\/doi.org\/10.1530\/JOE-18-0005.","journal-title":"J Endocrinol"},{"key":"3941_CR168","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/humrep\/dey045","volume":"33","author":"N Pascuali","year":"2018","unstructured":"Pascuali N, Scotti L, Di Pietro M, Oubi\u00f1a G, Bas D, May M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018;33:844\u201359. https:\/\/doi.org\/10.1093\/humrep\/dey045.","journal-title":"Hum Reprod"},{"key":"3941_CR169","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mce.2003.09.009","volume":"211","author":"PK Donahoe","year":"2003","unstructured":"Donahoe PK, Clarke T, Teixeira J, Maheswaran S, MacLaughlin DT. Enhanced purification and production of M\u00fcllerian inhibiting substance for therapeutic applications. Mol Cell Endocrinol. 2003;211:37\u201342. https:\/\/doi.org\/10.1016\/j.mce.2003.09.009.","journal-title":"Mol Cell Endocrinol"},{"key":"3941_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4782","volume":"34","author":"AY Rak","year":"2020","unstructured":"Rak AY, Trofimov AV, Pigareva NV, Protasov EA, Karabanova EA, Ischenko AM. Purification of human recombinant anti-Mullerian hormone and its derivatives. Biomed Chromatogr. 2020;34:e4782. https:\/\/doi.org\/10.1002\/bmc.4782.","journal-title":"Biomed Chromatogr"},{"key":"3941_CR171","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.rbmo.2018.08.012","volume":"37","author":"JM Ferguson","year":"2018","unstructured":"Ferguson JM, P\u00e9pin D, Duru C, Matejtschuk P, Donahoe PK, Burns CJ. Towards international standardization of immunoassays for M\u00fcllerian inhibiting substance\/anti-M\u00fcllerian hormone. Reprod Biomed Online. 2018;37:631\u201340. https:\/\/doi.org\/10.1016\/j.rbmo.2018.08.012.","journal-title":"Reprod Biomed Online"},{"key":"3941_CR172","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/JOE-15-0206","volume":"226","author":"IS McLennan","year":"2015","unstructured":"McLennan IS, Pankhurst MW. Anti-M\u00fcllerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J Endocrinol. 2015;226:R45-57. https:\/\/doi.org\/10.1530\/JOE-15-0206.","journal-title":"J Endocrinol"},{"key":"3941_CR173","doi-asserted-by":"publisher","unstructured":"Stocker WA, Howard JA, Maskey S, Luan H, Harrison SG, Hart KN, et al. Characterization of the molecular mechanisms that govern anti-M\u00fcllerian hormone synthesis and activity. FASEB J [Internet]. 2024;38:e23377. Available from: https:\/\/doi.org\/10.1096\/fj.202301335RR","DOI":"10.1096\/fj.202301335RR"},{"key":"3941_CR174","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1210\/jc.2012-1070","volume":"97","author":"G Griesinger","year":"2012","unstructured":"Griesinger G, Dafopoulos K, Buendgen N, Cascorbi I, Georgoulias P, Zavos A, et al. Elimination half-life of anti-M\u00fcllerian hormone. J Clin Endocrinol Metab. 2012;97:2160\u20133. https:\/\/doi.org\/10.1210\/jc.2012-1070.","journal-title":"J Clin Endocrinol Metab"},{"key":"3941_CR175","doi-asserted-by":"publisher","unstructured":"Godin P, Nagykery N, Sicher N, Barnes JL, Miller AG, Bunner C, et al. Gene therapy delivery of anti-M\u00fcllerian hormone in prepubertal female domestic cats induces long-term sterilization. Nat Commun [Internet]. 2025;16:10747. Available from: https:\/\/doi.org\/10.1038\/s41467-025-65780-2","DOI":"10.1038\/s41467-025-65780-2"},{"key":"3941_CR176","doi-asserted-by":"publisher","unstructured":"Stocker WA, Olenick L, Maskey S, Skrombolas D, Luan H, Harrison SG, et al. Gene therapy with feline anti-M\u00fcllerian hormone analogs disrupts folliculogenesis and induces pregnancy loss in female domestic cats. Nat Commun [Internet]. 2025;16:1668. Available from: https:\/\/doi.org\/10.1038\/s41467-025-56924-5","DOI":"10.1038\/s41467-025-56924-5"},{"key":"3941_CR177","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.fertnstert.2018.05.034","volume":"110","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2018","unstructured":"Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril. 2018;110:380\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.034.","journal-title":"Fertil Steril"},{"key":"3941_CR178","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dmz027","volume":"25","author":"N Spears","year":"2019","unstructured":"Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25:673\u201393. https:\/\/doi.org\/10.1093\/humupd\/dmz027.","journal-title":"Hum Reprod Update"},{"key":"3941_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1449156","volume":"12","author":"X Wei","year":"2024","unstructured":"Wei X, Bjarkadottir BD, Nadjaja D, Sheikh S, Fatum M, Lane S, et al. Effect of AMH on primordial follicle populations in mouse ovaries and human pre-pubertal ovarian xenografts during doxorubicin treatment. Front Cell Dev Biol. 2024;12:1449156. https:\/\/doi.org\/10.3389\/fcell.2024.1449156.","journal-title":"Front Cell Dev Biol"},{"key":"3941_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-33-46","volume":"33","author":"PG Signorile","year":"2014","unstructured":"Signorile PG, Petraglia F, Baldi A. Anti-M\u00fcllerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells. J Exp Clin Cancer Res. 2014;33:46. https:\/\/doi.org\/10.1186\/1756-9966-33-46.","journal-title":"J Exp Clin Cancer Res"},{"key":"3941_CR181","doi-asserted-by":"publisher","unstructured":"Uri-Belapolsky S, Shaish A, Eliyahu E, Grossman H, Levi M, Chuderland D, et al. Interleukin-1 deficiency prolongs ovarian lifespan in mice. Proc Natl Acad Sci U S A [Internet]. 2014;111:12492\u20137. Available from: https:\/\/doi.org\/10.1073\/pnas.1323955111","DOI":"10.1073\/pnas.1323955111"},{"key":"3941_CR182","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-16-0522","volume":"233","author":"MW Pankhurst","year":"2017","unstructured":"Pankhurst MW. A putative role for anti-M\u00fcllerian hormone (AMH) in optimising ovarian reserve expenditure. J Endocrinol. 2017;233:R1-13. https:\/\/doi.org\/10.1530\/JOE-16-0522.","journal-title":"J Endocrinol"},{"key":"3941_CR183","doi-asserted-by":"publisher","first-page":"223","DOI":"10.11005\/jbm.2021.28.3.223","volume":"28","author":"JH Kim","year":"2021","unstructured":"Kim JH, Yang YR, Kwon K-S, Kim N. Anti-M\u00fcllerian hormone negatively regulates osteoclast differentiation by suppressing the receptor activator of nuclear factor-\u03baB ligand pathway. J Bone Metab. 2021;28:223\u201330. https:\/\/doi.org\/10.11005\/jbm.2021.28.3.223.","journal-title":"J Bone Metab"},{"key":"3941_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105716","volume":"115","author":"C Racine","year":"2025","unstructured":"Racine C, Fraissinet F, Tolu S, Pereira T, Gil S, Badel A, et al. A blocking antibody against anti-M\u00fcllerian hormone restores ovulation and normal androgen levels in a spontaneous rat model of polycystic ovary syndrome. EBioMedicine. 2025;115:105716. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105716.","journal-title":"EBioMedicine"},{"issue":"6","key":"3941_CR185","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.cmet.2025.03.013","volume":"37","author":"L Cotellessa","year":"2025","unstructured":"Cotellessa L, Sobrino V, Silva MSB, Delit M, Maitre H, Caron E, et al. Preventing and correcting polycystic ovary syndrome by targeting anti-M\u00fcllerian hormone signaling in minipuberty and adulthood in mice. Cell Metab. 2025;37(6):1260. https:\/\/doi.org\/10.1016\/j.cmet.2025.03.013.","journal-title":"Cell Metab"},{"key":"3941_CR186","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43419","volume":"15","author":"H Mohammad","year":"2023","unstructured":"Mohammad H, S JC, Haripriya G, Maskeri D, K P, Priya P. Model of anti-M\u00fcllerian hormone over age to predict menopause in polycystic ovary syndrome and eumenorrheic women: a study on southern Indian population. Cureus. 2023;15:e43419. https:\/\/doi.org\/10.7759\/cureus.43419.","journal-title":"Cureus"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03941-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03941-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03941-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:25:01Z","timestamp":1787747101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-026-03941-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":186,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3941"],"URL":"https:\/\/doi.org\/10.1007\/s10815-026-03941-y","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Some figures have been made\/modified using Biorender.","order":1,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Language editing for this manuscript was performed with the assistance of OpenAI\u2019s ChatGPT, a language model designed for generating and refining text. All suggestions provided by the model have been proofread and verified by the authors. The use of this tool was for linguistic improvement only, and no generative content was created. No changes were made to the scientific content of the manuscript.","order":2,"name":"Ethics","label":"AI and software","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests related to this mini-review.","order":6,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}